FindTrial
Sign In

Drug Hypersensitivity To Common OPD Drugs By Preliminary Patch Testing.

Evaluation of preliminary patch testing in patients with suspected adverse drug reactions in a tertiary care hospital,Kancheepuram ditrict -A cross sectional study .

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/02/017843
Enrollment
75
Registered
2019-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z00-Z99- Factors influencing health status and contact with health services

Interventions

Intervention1: nil: nil

Sponsors

IADVLIndian Association Of Dermatologists Venereologists and Leprologists
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients with prior history of drug allergy to opd prescription drugs.

Exclusion criteria

Exclusion criteria: patients with severe adverse drug reactions -SJS,TEN.

Design outcomes

Primary

MeasureTime frame
To Evaluate the number of patients testing positive for drug allergy in patch testingTimepoint: 6 months -reactive patients 1 year 2 year—

Secondary

MeasureTime frame
To evaluate cross reactivity between different prescription drugs during patch testing .Timepoint: Dec 2019 Dec 2020—

Countries

India

Contacts

Public ContactDr Sudarvizhi

Karpaga Vinayaka Institute of medical Sciences.

drdhanuk@gmail.com9566120848

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026